HUP9902293A3 - Stabilized antihepatitis-b vaccine tablets - Google Patents

Stabilized antihepatitis-b vaccine tablets

Info

Publication number
HUP9902293A3
HUP9902293A3 HU9902293A HUP9902293A HUP9902293A3 HU P9902293 A3 HUP9902293 A3 HU P9902293A3 HU 9902293 A HU9902293 A HU 9902293A HU P9902293 A HUP9902293 A HU P9902293A HU P9902293 A3 HUP9902293 A3 HU P9902293A3
Authority
HU
Hungary
Prior art keywords
antihepatitis
stabilized
vaccine
tablets
vaccine tablets
Prior art date
Application number
HU9902293A
Other languages
Hungarian (hu)
Original Assignee
Rothschild Peter R Mcallen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rothschild Peter R Mcallen filed Critical Rothschild Peter R Mcallen
Publication of HUP9902293A2 publication Critical patent/HUP9902293A2/en
Publication of HUP9902293A3 publication Critical patent/HUP9902293A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
HU9902293A 1996-04-22 1997-03-31 Stabilized antihepatitis-b vaccine tablets HUP9902293A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63551496A 1996-04-22 1996-04-22

Publications (2)

Publication Number Publication Date
HUP9902293A2 HUP9902293A2 (en) 1999-11-29
HUP9902293A3 true HUP9902293A3 (en) 2000-04-28

Family

ID=24548102

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9902293A HUP9902293A3 (en) 1996-04-22 1997-03-31 Stabilized antihepatitis-b vaccine tablets

Country Status (8)

Country Link
EP (1) EP0914141A1 (en)
JP (1) JP2000509036A (en)
KR (1) KR20000010591A (en)
CN (1) CN1216471A (en)
AU (1) AU2520397A (en)
CA (1) CA2285184A1 (en)
HU (1) HUP9902293A3 (en)
WO (1) WO1997039762A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541001B1 (en) * 1999-08-24 2003-04-01 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
US6592869B2 (en) 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57136528A (en) * 1981-02-09 1982-08-23 Hayashibara Biochem Lab Inc Preparation of viral vaccine
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
DE59307073D1 (en) * 1992-01-17 1997-09-11 Alfatec Pharma Gmbh PELLETS CONTAINING PEPTIC DRUGS AND THEIR PRODUCTION AND USE THEREOF

Also Published As

Publication number Publication date
EP0914141A1 (en) 1999-05-12
CA2285184A1 (en) 1997-10-30
WO1997039762A1 (en) 1997-10-30
CN1216471A (en) 1999-05-12
JP2000509036A (en) 2000-07-18
HUP9902293A2 (en) 1999-11-29
AU2520397A (en) 1997-11-12
KR20000010591A (en) 2000-02-15

Similar Documents

Publication Publication Date Title
IL128985A0 (en) Vaccines
GB9712347D0 (en) Vaccine
GB9718901D0 (en) Vaccine
IL136447A0 (en) Vaccine
GB9711990D0 (en) Vaccine
GB9726555D0 (en) Vaccine
GB9720585D0 (en) Vaccine
GB9602080D0 (en) Pharmaceutical compounds
EP0958373A4 (en) Vaccines
GB9715490D0 (en) Pharmaceutical preparation
GB9609976D0 (en) Pharmaceutical compounds
AU132520S (en) Tablet
EP0907644A4 (en) Pharmaceutical preparation
ZA9711565B (en) Vaccine
EP0923564A4 (en) Pharmaceutical compounds
AU133610S (en) Tablet
HUP9902293A3 (en) Stabilized antihepatitis-b vaccine tablets
GB9625968D0 (en) Vaccine
ZA973824B (en) Vaccines
GB9625966D0 (en) Vaccine
GB9625967D0 (en) Vaccine
GB9608926D0 (en) Novel pharmaceutical
GB9605229D0 (en) Vaccines
GB9606032D0 (en) Vaccines
GB9604595D0 (en) Vaccines